Callan Capital »

Halozyme Therapeutics shares owned by Callan Capital

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Callan Capital from 13F filings

Historical chart of Callan Capital investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Callan Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Callan Capital

Quarter filed Position value Share count Share price at filing
2013-03-31 $962k 159k 6.04
2012-12-31 $1.1M 159k 6.71

More positions owned by Callan Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Meta Platforms Cl A (META)
Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Fundamental Intl (FNDF)
NVIDIA Corporation (NVDA)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Apple (AAPL)
Schwab Strategic Tr Fundamental Us B (FNDB)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Goldman Sachs Etf Tr Activebeta Int (GSIE)

View all positions for Callan Capital

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Bank of America Corporation
Alliancebernstein
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Invesco
Congress Asset Management
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics